Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
BMC Genom Data. 2023 Feb 14;24(1):6. doi: 10.1186/s12863-023-01114-9.
Thrombocytopenia is a condition that causes a low amount of blood platelets. Platelets are blood cells that play an essential role in blood coagulation. Therefore, thrombocytopenia can put the patient at risk for mild to severe bleeding. Thrombocytopenia is caused by a decrease in platelet production in the bone marrow or by a drug or immune system problem when production is normal. In particular, in some ASO-induced thrombocytopenia, the mechanism is not clear. Therefore, whole genome sequencing (WGS) was performed to discover genetic differences that affect thrombocytopenia and individual susceptibility to drugs between normal and reduced platelet monkeys despite administering the same ASO.
Three antisense oligonucleotide (ASO) substances were injected into the subcutaneous tissue of monkeys for 12 weeks in two experiments. The monkeys were classified into three groups: monkeys with thrombocytopenia, monkeys without thrombocytopenia, and control monkeys not treated with ASO substances. Whole genome sequencing data was generated using liver tissues of monkeys. These data will be useful for identifying genetic differences that affect thrombocytopenia and drug sensitivity.
血小板减少症是一种导致血液血小板数量减少的病症。血小板是在血液凝结中起关键作用的血细胞。因此,血小板减少症会使患者面临轻度至重度出血的风险。血小板减少症是由骨髓中血小板生成减少或药物或免疫系统问题引起的,而此时血小板生成正常。特别是在一些由 ASO 引起的血小板减少症中,其机制尚不清楚。因此,进行全基因组测序 (WGS) 以发现遗传差异,这些差异会影响正常和血小板减少的猴子对药物的易感性和血小板减少症,尽管对猴子施用相同的 ASO。
在两项实验中,将三种反义寡核苷酸 (ASO) 物质注射到猴子的皮下组织中 12 周。将猴子分为三组:血小板减少症猴子、无血小板减少症猴子和未用 ASO 物质治疗的对照猴子。使用猴子的肝组织生成全基因组测序数据。这些数据将有助于确定影响血小板减少症和药物敏感性的遗传差异。